Concepedia

Daniel C. Poon

DC

Statistics

Publications

3

Citations

100

H-Index

3

Active since

2015

Affiliations

Chinese University of Hong Kong(Current)

Sun Yat-sen University Cancer Center

Sun Yat-sen University

Daniel C. Poon is an author at Chinese University of Hong Kong specializing in cancer pharmacology, medicine, and pharmacology.

Publications per year

2015–2016

3

Publications

3

Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia

Kenneth K.W. To, Daniel C. Poon, Yuming Wei et al. · Biochemical Pharmacology · 2015 · 50 citations

, , +10

Pelitinib (<scp>EKB</scp>‐569) targets the up‐regulation of <scp>ABCB</scp>1 and <scp>ABCG</scp>2 induced by hyperthermia to eradicate lung cancer

Kenneth K.W. To, Daniel C. Poon, Yuming Wei et al. · British Journal of Pharmacology · 2015 · 40 citations · Full text

, , +17

A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors

Yuming Wei, Daniel C. Poon, Rong Fei et al. · Scientific Reports · 2016 · 10 citations · Full text

, , +17

1–3 of 3